Cardionovum | Aperto OTW | Which Medical Device
From Cardionovum
Less Shunt Restenosis improves Hemodialysis Patients? Quality of Life! APERTO SHUNT DCB protects AV fistulas and shunt grafts from early restenosis. For the prevention and successful dilatation of intimal hyperplasia.
Shunt restenosis represents a common threat to the function of arteriovenous fistulas (AVFs) and shunt grafts in patients on hemodialysis. Patients often develop a consecutive neointimal hyperplasia in hemodialysis access vessels as well as along the needle puncture site.
The new APERTO DCB Paclitaxel releasing, high pressure balloon dilatation catheter provides a dual shunt treatment quality for the prevention and dilatation of intimal hyperplasia. AVF or PTFE shunt graft venous outflow lesions can be treated very successfully by the new APERTO OTW leading to a substantial reduction of hemodialysis shunt restenosis, for a prolonged dialysis access survival.
Your opinion matters to others - rate this device or add a comment
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.
